Benzinga · Nov 6, 2026
Datavault AI Stock Rallies After Board Fires CEO, Several Execs Replaced
Datavault AI shares jumped after a leadership overhaul that followed invalidated financial statements tied to a $150 million Bitcoin deal.
NASDAQ · SCLX
Scilex Holding Company
Healthcare · Drug Manufacturers - General
$1.56
Down-$0.06 (-3.70%)
Updated Nov 13, 2026, 11:44 AM
SID Score
2.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 144.1M
- P/E ratio
- -0.52
- Dividend yield
- 0.00%
- 52-week range
- $1.54 – $27.00
- Volume
- 48.23K
- Avg. volume
- 202.34K
Price performance · SCLX
SCLX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 12, 2026
SCLX closed at $1.56 after 21 trading sessions, down 44.68% for the selected period.
- Last close
- $1.56
- Period change
- -44.68%
- Period low
- $1.56
- Period high
- $2.83
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | $1.61 | $1.6575 | $1.54 | $1.56 | 48.23K |
| Nov 11, 2026 | $1.62 | $1.6516 | $1.61 | $1.62 | 14.49K |
| Nov 10, 2026 | $1.74 | $1.775 | $1.61 | $1.61 | 31.38K |
| Nov 9, 2026 | $1.69 | $1.77 | $1.64 | $1.74 | 27.91K |
| Nov 6, 2026 | $1.70 | $1.78 | $1.6645 | $1.70 | 20.82K |
| Nov 5, 2026 | $1.83 | $1.83 | $1.61 | $1.70 | 79.91K |
| Nov 4, 2026 | $1.95 | $1.9899 | $1.81 | $1.83 | 32.92K |
| Nov 3, 2026 | $1.85 | $2.00 | $1.85 | $1.85 | 46.2K |
| Nov 2, 2026 | $1.88 | $2.09 | $1.85 | $1.87 | 54.91K |
| Oct 30, 2026 | $2.05 | $2.0638 | $1.83 | $1.85 | 49.88K |
| Oct 29, 2026 | $2.09 | $2.17 | $2.05 | $2.06 | 7.39K |
| Oct 28, 2026 | $2.01 | $2.10 | $2.01 | $2.09 | 17.02K |
| Oct 27, 2026 | $2.32 | $2.34 | $2.01 | $2.05 | 99.28K |
| Oct 26, 2026 | $2.35 | $2.40 | $2.28 | $2.33 | 47.85K |
| Oct 23, 2026 | $2.44 | $2.48 | $2.27 | $2.35 | 35.22K |
| Oct 22, 2026 | $2.56 | $2.60 | $2.449 | $2.47 | 33.42K |
| Oct 21, 2026 | $2.51 | $2.62 | $2.51 | $2.56 | 25.89K |
| Oct 20, 2026 | $2.55 | $2.68 | $2.52 | $2.53 | 35.74K |
| Oct 19, 2026 | $2.81 | $2.81 | $2.518 | $2.57 | 52.15K |
| Oct 16, 2026 | $2.82 | $2.8903 | $2.77 | $2.83 | 29.52K |
| Oct 15, 2026 | $2.83 | $2.85 | $2.77 | $2.82 | 12.54K |
Latest SCLX news
The latest Smart Investors Daily articles mentioning SCLX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
SCLX research
Overview
Company profile and research snapshot.
Company profile
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Apr 11, 2025 | D. Boral Capital | Hold | — |
| Apr 2, 2025 | D. Boral Capital | Buy | — |
| Feb 28, 2025 | D. Boral Capital | Buy | — |
| Jan 27, 2025 | D. Boral Capital | Buy | — |
| Oct 21, 2024 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Nov 6, 2026
Datavault AI Fires CEO Nathaniel Bradley
Datavault AI ousts CEO Nathaniel Bradley amid scrutiny over a $150M Bitcoin deal restatement and going-concern risks. Get the latest.
Benzinga · Oct 27, 2026
Datavault AI Stock Crashes — Financials Cannot Be Trusted: What You Need to Know
Datavault AI shares plunge nearly 40% after invalidating financial statements tied to a $150M Bitcoin deal.
Yahoo · Oct 22, 2026
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies
* Proprietary IP Position Until At Least 2042 to Enable Consolidation of Infrastructure targeting market expected to grow from $9. ("Datavault AI") (NASDAQ:DVLT), Data Health Partners, Inc.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
